Search results
Results from the WOW.Com Content Network
SARS was a relatively rare disease; at the end of the epidemic in June 2003, the incidence was 8,422 cases with a case fatality rate (CFR) of 11%. [5] No cases of SARS-CoV-1 have been reported worldwide since 2004. [6] In December 2019, a second strain of SARS-CoV was identified: SARS-CoV-2. [7]
The 2002–2004 outbreak of SARS, caused by severe acute respiratory syndrome coronavirus (SARS-CoV or SARS-CoV-1), infected over 8,000 people from 30 countries and territories, and resulted in at least 774 deaths worldwide. [1] The outbreak was first identified in Foshan, Guangdong, China, in November 2002. [2]
A map of SARS cases and deaths around the world regarding the global population, not just HCWs. The rapid spread of severe acute respiratory syndrome (SARS) in healthcare workers (HCW)—most notably in Toronto, Ontario hospitals—during the global outbreak of SARS in 2002–2003 contributed to dozens of identified cases, some of them fatal.
SARS-related coronavirus is a member of the genus Betacoronavirus (group 2) and monotypic of the subgenus Sarbecovirus (subgroup B). [13] Sarbecoviruses, unlike embecoviruses or alphacoronaviruses, have only one papain-like proteinase (PLpro) instead of two in the open reading frame ORF1ab. [14]
2002–2004 SARS outbreak: 2002–2004 Worldwide Severe acute respiratory syndrome / SARS: 774 [234] 2003–2019 Asia and Egypt avian influenza epidemic 2003–2019 China, Southeast Asia and Egypt: Influenza A virus subtype H5N1: 455 [235] 2004 Indonesia dengue epidemic 2004 Indonesia: Dengue fever: 658 [236] 2004 Sudan Ebola outbreak 2004 ...
Scanning electron micrograph of SARS virions. Severe acute respiratory syndrome (SARS) is the disease caused by SARS-CoV-1. It causes an often severe illness and is marked initially by systemic symptoms of muscle pain, headache, and fever, followed in 2–14 days by the onset of respiratory symptoms, [13] mainly cough, dyspnea, and pneumonia.
SARS-CoV-2 is the seventh known coronavirus to infect people, after 229E, NL63, OC43, HKU1, MERS-CoV, and the original SARS-CoV. [105] Like the SARS-related coronavirus implicated in the 2003 SARS outbreak, SARS‑CoV‑2 is a member of the subgenus Sarbecovirus (beta-CoV lineage B). [106] [107] Coronaviruses undergo frequent recombination. [108]
During 2023, SARS-CoV-2 continued to circulate in the global population and to evolve, with a number of new subvariants. Testing, sequencing and reporting rates reduced. [223] BA.2.86 was first detected in a sample from 24 July 2023, and was designated as a variant under monitoring by the World Health Organization on 17 August 2023. [224]